GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **2976 - 3000** of **4050** in total

« First

‹ Prev

…

116

117

118

119

120

121

122

123

124

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgM	Patient 1	10	moderate	G72424VO	70
IgM	Patient 1	22	moderate	G72424VO	229
IgG	Patient 1	6	moderate	G72424VO	25
IgM	Patient 1	6	moderate	G72424VO	39
IgA	Patient 2	15	mild	G72424VO	445
IgA	Patient 2	24	mild	G72424VO	543
IgG	Patient 2	15	mild	G72424VO	74
IgG	Patient 2	24	mild	G72424VO	79
IgM	Patient 2	15	mild	G72424VO	185
IgM	Patient 2	24	mild	G72424VO	228
IgA	Patient 2	3	mild	G72424VO	559
IgG	Patient 2	3	mild	G72424VO	94
IgM	Patient 2	3	mild	G72424VO	276
IgA	Patient 3	-180	mild	G72424VO	265
IgA	Patient 3	11	mild	G72424VO	486
IgG	Patient 3	-180	mild	G72424VO	44
IgM	Patient 3	-180	mild	G72424VO	84
IgA	Patient 3	4	mild	G72424VO	402
IgG	Patient 3	11	mild	G72424VO	50
IgG	Patient 3	4	mild	G72424VO	47
IgM	Patient 3	11	mild	G72424VO	179
IgM	Patient 3	4	mild	G72424VO	133
IgA	Patient 4	12	mild	G72424VO	443
IgG	Patient 4	12	mild	G72424VO	71
IgM	Patient 4	12	mild	G72424VO	158